Progress in defining progression in NMIBC

The International Bladder Cancer Group has proposed a new definition for disease progression in non-muscle-invasive bladder cancer that includes stage and grade progression. Although this definition will inevitably be subject to changes, it can currently be regarded as the gold standard for future t...

Full description

Saved in:
Bibliographic Details
Published inNature reviews. Urology Vol. 10; no. 12; pp. 684 - 685
Main Authors Gierth, Michael, Burger, Maximilian
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.12.2013
Nature Publishing Group
Subjects
631/67/589/1336
692/699/2768/1336
692/699/2768/589/1336
692/699/67/589/1336
Bladder cancer
Care and treatment
Development and progression
Medicine
Medicine & Public Health
news-and-views
Urology
Germany
Online AccessGet full text

Cover

Abstract The International Bladder Cancer Group has proposed a new definition for disease progression in non-muscle-invasive bladder cancer that includes stage and grade progression. Although this definition will inevitably be subject to changes, it can currently be regarded as the gold standard for future trials, publications and protocols.
AbstractList The International Bladder Cancer Group has proposed a new definition for disease progression in non-muscle-invasive bladder cancer that includes stage and grade progression. Although this definition will inevitably be subject to changes, it can currently be regarded as the gold standard for future trials, publications and protocols. Gierth, M. & Burger, M. Nat. Rev. Urol. 10, 684-685 (2013); published online 26 November 2013; doi: 10.1038/nrurol.2013.270
The International Bladder Cancer Group has proposed a new definition for disease progression in non-muscle-invasive bladder cancer that includes stage and grade progression. Although this definition will inevitably be subject to changes, it can currently be regarded as the gold standard for future trials, publications and protocols.
Audience Academic
Author Burger, Maximilian
Gierth, Michael
Author_xml – sequence: 1
  givenname: Michael
  surname: Gierth
  fullname: Gierth, Michael
  organization: Department of Urology, Caritas St Josef Medical Centre, University of Regensburg
– sequence: 2
  givenname: Maximilian
  surname: Burger
  fullname: Burger, Maximilian
  email: maximilian.burger@klinik.uni-regensburg.de
  organization: Department of Urology, Caritas St Josef Medical Centre, University of Regensburg
BookMark eNp9kMtLwzAcgINMcJuevQ4EwUO7vJq2xzl8DObjoOeQpkmX0SUj2Q7-96Z0iBOVHBJ-fF9CvhEYWGcVAJcIpgiSYmr93rs2xRCRFOfwBAxRnpUJLTAcfJ0RPgOjENYQMkZzNgQ3r941XoUwMXZSK22ssc1kexgaZ7v589Pidn4OTrVog7o47GPwfn_3Nn9Mli8Pi_lsmUiMM5jUWua4hFgXUJc1IozKCpGqrAiUNFM1klnNClJTSqtcMikYxlTBoqyzQqtCkDG46u9tRKu4sdrtvJAbEySfkSzDNC8xi1T6CxVXrTZGxjLaxPmRcP1NWCnR7lbBtftd_GM4BrMelN6F4JXm0uxEh8UXTMsR5F1v3vfmXW8ee0dv-sPberMR_uMfA_ZGiKRtlOdrt_c2xv1T-QRDMZOl
CitedBy_id crossref_primary_10_18632_oncotarget_5546
crossref_primary_10_1016_j_cca_2018_05_056
crossref_primary_10_1111_febs_13116
crossref_primary_10_18632_oncotarget_8635
crossref_primary_10_1186_s12894_016_0171_5
crossref_primary_10_1007_s11095_016_1920_6
Cites_doi 10.1016/j.eururo.2013.06.003
10.1016/j.eururo.2007.12.026
10.1038/nrurol.2012.252
10.1016/j.eururo.2012.05.033
10.1016/j.eururo.2009.06.028
10.1111/j.1442-2042.2007.01890.x
10.1111/j.1365-2559.2011.03989.x
10.1038/nrurol.2013.182
10.1016/j.juro.2013.07.102
10.1016/j.eururo.2006.10.037
ContentType Journal Article
Copyright Springer Nature Limited 2013
COPYRIGHT 2013 Nature Publishing Group
Copyright_xml – notice: Springer Nature Limited 2013
– notice: COPYRIGHT 2013 Nature Publishing Group
DBID AAYXX
CITATION
DOI 10.1038/nrurol.2013.270
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList



DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1759-4820
EndPage 685
ExternalDocumentID A355247926
10_1038_nrurol_2013_270
GeographicLocations Germany
GeographicLocations_xml – name: Germany
GroupedDBID ---
0R~
29M
39C
3V.
53G
70F
7X7
88E
8FI
8FJ
AAEEF
AARCD
AAWTL
AAWYQ
AAYZH
AAZLF
ABAWZ
ABJNI
ABLJU
ABUWG
ACGFS
ADBBV
AENEX
AFFVI
AFKRA
AFSHS
AGAYW
AGHTU
AHBCP
AHMBA
AHOSX
AHSBF
AIBTJ
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ARMCB
AXYYD
BENPR
BKKNO
BPHCQ
BVXVI
CCPQU
DB5
EBS
EE.
EJD
EXGXG
F5P
FQGFK
FSGXE
FYUFA
HMCUK
HZ~
IAO
IHR
IHW
INH
INR
ITC
M1P
NNMJJ
ODYON
OVD
PQQKQ
PROAC
PSQYO
RNR
RNT
RNTTT
S70
SHXYY
SIXXV
SNYQT
SOJ
TAOOD
TBHMF
TDRGL
TEORI
TSG
UKHRP
AAYXX
AFANA
ALPWD
ATHPR
CITATION
PHGZM
PHGZT
PMFND
ID FETCH-LOGICAL-c2250-dfc72902f80f9d1364cb13b9b30c45ed1c5d683d444b7c6ca6224e089d58fe8a3
ISSN 1759-4812
IngestDate Tue Jun 17 21:35:11 EDT 2025
Tue Jun 10 20:31:23 EDT 2025
Thu May 22 21:11:37 EDT 2025
Tue Jul 01 03:38:43 EDT 2025
Thu Apr 24 22:55:42 EDT 2025
Fri Feb 21 02:38:44 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 12
Language English
License http://www.springer.com/tdm
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c2250-dfc72902f80f9d1364cb13b9b30c45ed1c5d683d444b7c6ca6224e089d58fe8a3
PageCount 2
ParticipantIDs gale_infotracmisc_A355247926
gale_infotracacademiconefile_A355247926
gale_healthsolutions_A355247926
crossref_citationtrail_10_1038_nrurol_2013_270
crossref_primary_10_1038_nrurol_2013_270
springer_journals_10_1038_nrurol_2013_270
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20131200
PublicationDateYYYYMMDD 2013-12-01
PublicationDate_xml – month: 12
  year: 2013
  text: 20131200
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
PublicationTitle Nature reviews. Urology
PublicationTitleAbbrev Nat Rev Urol
PublicationYear 2013
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References BabjukMEAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013Eur. Urol.20136463965310.1016/j.eururo.2013.06.003
RazzakMBladder cancer: gaps in staging and care identifiedNat. Rev. Urol.20131049310.1038/nrurol.2013.182
Lamm, D. et al. Defining progression in non-muscle invasive bladder cancer (NMIBC): it's time for a new, standard definition. J. Urol.http://dx.doi.org/10.1016/j.juro.2013.07.102.
DenzingerSBladder sparing approach for initial T1G3 bladder cancer: do multifocality, size of tumor or concomitant carcinoma in situ matter? A long-term analysis of 132 patientsInt. J. Urol.20071499599910.1111/j.1442-2042.2007.01890.x
BurgerMPrediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective studyEur. Urol.20085483584310.1016/j.eururo.2007.12.026
BertzSSubstaging by estimating the size of invasive tumour can improve risk stratification in pT1 urothelial bladder cancer-evaluation of a large hospital-based single-centre seriesHistopathology20115972273210.1111/j.1365-2559.2011.03989.x
van RhijnBWRecurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategyEur. Urol.20095643043210.1016/j.eururo.2009.06.028
MacLennanGTKirkaliZChengLHistologic grading of noninvasive papillary urothelial neoplasmsEur. Urol.20075188989710.1016/j.eururo.2006.10.037
Bertz, S. et al. Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer. Eur. Urol.http://dx.doi.org/10.1016/j.eururo.2012.05.033.
NoonAPCattoJWBladder cancer in 2012: challenging current paradigmsNat. Rev. Urol.20131067681:CAS:528:DC%2BC3sXis1Cnu7g%3D10.1038/nrurol.2012.252
M Burger (BFnrurol2013270_CR4) 2008; 54
S Denzinger (BFnrurol2013270_CR7) 2007; 14
GT MacLennan (BFnrurol2013270_CR6) 2007; 51
BFnrurol2013270_CR1
AP Noon (BFnrurol2013270_CR10) 2013; 10
BW van Rhijn (BFnrurol2013270_CR5) 2009; 56
BFnrurol2013270_CR9
M Babjuk (BFnrurol2013270_CR2) 2013; 64
M Razzak (BFnrurol2013270_CR3) 2013; 10
S Bertz (BFnrurol2013270_CR8) 2011; 59
References_xml – reference: DenzingerSBladder sparing approach for initial T1G3 bladder cancer: do multifocality, size of tumor or concomitant carcinoma in situ matter? A long-term analysis of 132 patientsInt. J. Urol.20071499599910.1111/j.1442-2042.2007.01890.x
– reference: RazzakMBladder cancer: gaps in staging and care identifiedNat. Rev. Urol.20131049310.1038/nrurol.2013.182
– reference: NoonAPCattoJWBladder cancer in 2012: challenging current paradigmsNat. Rev. Urol.20131067681:CAS:528:DC%2BC3sXis1Cnu7g%3D10.1038/nrurol.2012.252
– reference: BurgerMPrediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective studyEur. Urol.20085483584310.1016/j.eururo.2007.12.026
– reference: Bertz, S. et al. Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer. Eur. Urol.http://dx.doi.org/10.1016/j.eururo.2012.05.033.
– reference: BabjukMEAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013Eur. Urol.20136463965310.1016/j.eururo.2013.06.003
– reference: van RhijnBWRecurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategyEur. Urol.20095643043210.1016/j.eururo.2009.06.028
– reference: MacLennanGTKirkaliZChengLHistologic grading of noninvasive papillary urothelial neoplasmsEur. Urol.20075188989710.1016/j.eururo.2006.10.037
– reference: BertzSSubstaging by estimating the size of invasive tumour can improve risk stratification in pT1 urothelial bladder cancer-evaluation of a large hospital-based single-centre seriesHistopathology20115972273210.1111/j.1365-2559.2011.03989.x
– reference: Lamm, D. et al. Defining progression in non-muscle invasive bladder cancer (NMIBC): it's time for a new, standard definition. J. Urol.http://dx.doi.org/10.1016/j.juro.2013.07.102.
– volume: 64
  start-page: 639
  year: 2013
  ident: BFnrurol2013270_CR2
  publication-title: Eur. Urol.
  doi: 10.1016/j.eururo.2013.06.003
– volume: 54
  start-page: 835
  year: 2008
  ident: BFnrurol2013270_CR4
  publication-title: Eur. Urol.
  doi: 10.1016/j.eururo.2007.12.026
– volume: 10
  start-page: 67
  year: 2013
  ident: BFnrurol2013270_CR10
  publication-title: Nat. Rev. Urol.
  doi: 10.1038/nrurol.2012.252
– ident: BFnrurol2013270_CR9
  doi: 10.1016/j.eururo.2012.05.033
– volume: 56
  start-page: 430
  year: 2009
  ident: BFnrurol2013270_CR5
  publication-title: Eur. Urol.
  doi: 10.1016/j.eururo.2009.06.028
– volume: 14
  start-page: 995
  year: 2007
  ident: BFnrurol2013270_CR7
  publication-title: Int. J. Urol.
  doi: 10.1111/j.1442-2042.2007.01890.x
– volume: 59
  start-page: 722
  year: 2011
  ident: BFnrurol2013270_CR8
  publication-title: Histopathology
  doi: 10.1111/j.1365-2559.2011.03989.x
– volume: 10
  start-page: 493
  year: 2013
  ident: BFnrurol2013270_CR3
  publication-title: Nat. Rev. Urol.
  doi: 10.1038/nrurol.2013.182
– ident: BFnrurol2013270_CR1
  doi: 10.1016/j.juro.2013.07.102
– volume: 51
  start-page: 889
  year: 2007
  ident: BFnrurol2013270_CR6
  publication-title: Eur. Urol.
  doi: 10.1016/j.eururo.2006.10.037
SSID ssj0066476
Score 1.9848491
Snippet The International Bladder Cancer Group has proposed a new definition for disease progression in non-muscle-invasive bladder cancer that includes stage and...
SourceID gale
crossref
springer
SourceType Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 684
SubjectTerms 631/67/589/1336
692/699/2768/1336
692/699/2768/589/1336
692/699/67/589/1336
Bladder cancer
Care and treatment
Development and progression
Medicine
Medicine & Public Health
news-and-views
Urology
Title Progress in defining progression in NMIBC
URI https://link.springer.com/article/10.1038/nrurol.2013.270
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9UwFA-6gfgydFOc27QPwjak19wkTdPHIbop3MseduG-lXzKhVnl7g7G_npPPtq10wtzL6WcnqZJfsnJSXo-EPogrbNMSZ1XotA5zMQyV4bY3GHgN1wpib2D82TKz2bs-7yYtwnGk3fJSo307T_9Sh6DKtAAV-8l-x_IdoUCAe4BX7gCwnB9EMbn3rjKi6pg0upCrodocRWjbXj6dPItZa9OKug0hPJMPitXo4-z5eBk_RTWyXjW0reojw4PPyK-E3mz-Lm4bAdWOjMY0579RRRzZVHlTCQDZtunETyQjbg_BkhP0vGY2S0tmjzm3flLHsfo683yGpri7ejoiMQ8IcPI1_dWpM5OMPwhp6KOBdS-gBoKeIo2CewKfMKKct7trzlnIZdg17g2khMVn-7VYKCEtEvx8Ed40C8uXqCttDHITiLKL9ET22yjZ5Nk-rCDjluws0WTtWBnPbA9PYD9Cs2-frn4fJanPBe5BmmKc-M0bHEwcQK7yowpZ1qNqaoUxZoV1ox1YbighjGmSs215KB3WSwqUwhnhaSv0Ubzq7FvUKaYUNg5oqUwzIpSAldhoK98JDd4dxeN2obXOgWB97lILus1Xb2LjroXfsf4J-tZ3_uerKMDbze_6hNQaQkrKwJfPwwcfojAV7VMLiBQdx-FbMC5P-AEmacHj49btOo0H6_WVevtw1uwh57fzZZ9tLFaXtsD0DlX6l0YaX8AYQqAHA
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Progress+in+defining+progression+in+NMIBC&rft.jtitle=Nature+reviews.+Urology&rft.au=Gierth%2C+Michael&rft.au=Burger%2C+Maximilian&rft.date=2013-12-01&rft.issn=1759-4812&rft.eissn=1759-4820&rft.volume=10&rft.issue=12&rft.spage=684&rft.epage=685&rft_id=info:doi/10.1038%2Fnrurol.2013.270&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_nrurol_2013_270
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1759-4812&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1759-4812&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1759-4812&client=summon